Back to User profile » Dr Camille C Gunderson
Paper published by Dr Camille C Gunderson:
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
Dockery LE, Gunderson CC, Moore KN
OncoTargets and Therapy 2017, 10:3029-3037
Published Date: 19 June 2017